Clinical Trials in Israel

Active recruiting clinical trials with sites in Israel. Select a condition below to see detailed trial listings.

Total Trials: 77 // Recruiting: 77 // Updated: Daily

Israel currently has 77 clinical trials with at least one registered site in the country, of which 77 are actively recruiting participants. The most studied conditions at Israel sites are Non Small Cell Lung Cancer, Crohn Disease, Plasma Cell Myeloma Refractory, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including Sheba Medical Center, Hadassah Medical Organization, Merck Sharp & Dohme LLC. By stage, active Israel trials break down as Phase 1 (10), Phase 2 (15), Phase 3 (5), Phase 4 (3). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Israel

Non Small Cell Lung Cancer 2 Crohn Disease 2 Plasma Cell Myeloma Refractory 1 Renal Cell Carcinoma (Kidney Cancer) 1 Hepatocellular Carcinoma 1 Transitional Cell Carcinoma 1 Labor Induction 1 Cervical Ripening and Induction of Labor 1 Ovarian Cancer Recurrent 1 Traumatic Brain Injury (TBI) Patients 1 Healthy Participants 1 Non-TBI Trauma 1 Rectal Cancer 1 Rectal Tumor 1 Rectal/Anal 1 Colon Polyp 1 Breakthrough Pain 1 Infertility 1 Autism 1 Autism Spectrum Disorder 1

All Countries → All Trials →

Other Countries in This Region

🇹🇷Turkey

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology